EastGate Biotech (ETBI) announced that it signed a non-dilutive licensing deal with a European consortium of several medium sized drug makers that gives them rights to market the oral insulin mouth rinse to the European market. The consortium will have a 15 year exclusive license with a 10% royalty payable to ETBI. Nico Innovagroup mentioned […]
ETBI
EastGate’s (ETBI) 8K Filing Re-Solidifies Its Goal to Go Current
EastGate’s 8K Filing Re-Solidifies Its Goal to Go Current New audit team; Soon to be current Oral mouth rinse a safer alternative than needles for diabetics Dual list on the Canadian Stock Exchange 1st tranche of up to $5 million investment was due in May Company using the East to West Approval strategy EastGate Biotech […]
